Cost-effective analysis by government bureaucrats is keeping the life-saving drug off the vaccine schedule in both the United States and Canada.
To discourage rationing and promote that health care decisions are made by patients and doctors, not government, the Institute for Liberty has provided an article that discusses the need for the infant meningitis vaccine.
Tomorrow, the CDC will be holding one of it’s four “public meetings” in Chicago. Heartland representatives will be attending the meeting to ask serious questions: Is cost-effective analysis keeping a life-saving vaccine off the schedule? What effect does this analysis have on consumer choice? How will cost-effective analysis hinder future drug innovation?